SALT LAKE CITY and OXFORD, United Kingdom, Nov. 1, 2024 /PRNewswire/ — Wasatch Biolabs (WBL), a disruptive R&D and high-throughput medical laboratory, at present introduced a collaboration with Oxford Nanopore Applied sciences (ONT), the corporate delivering a brand new technology of nanopore-based molecular sensing expertise, to develop a Direct Complete Methylome Sequencing product that addresses key limitations related to conventional bisulfite sequencing and methylation microarrays.
WBL develops proprietary methylation and genomic assays for mass-market analysis and customised medical purposes incorporating Oxford Nanopore’s wealthy genomic insights and speedy, accessible, and reasonably priced sequencing expertise. This collaboration is designed to construct on Wasatch BioLab’s present proprietary methylation assays and create market-leading affords to drive innovation in genomic and epigenomic evaluation, accelerating breakthroughs in analysis and medical purposes.
“Via this collaboration, we’re using Oxford Nanopore’s industry-leading sequencing expertise and extra technological experience to speed up product growth and produce groundbreaking improvements to market sooner,” mentioned Chad Pollard, CEO and Co-Founding father of Wasatch BioLabs. “These merchandise are poised to redefine the usual for epigenetic analysis and revolutionize the sector.”
New Product Announcement: Direct Complete Methylome Sequencing
Following Wasatch BioLabs’ current launch of a cell-free complete genome methylation sequencing assay that considerably improves sensitivity and information high quality in assays focusing on extremely fragmented cfDNA, WBL is happy to announce their newest product: Direct Complete Methylome Sequencing (dWMS). This modern expertise addresses key limitations of conventional strategies, corresponding to bisulfite sequencing and methylation microarrays.
By eliminating DNA harm from harsh chemical remedies, sequencing biases from PCR amplification, batch results, and restricted genomic protection, dWMS affords complete genome-wide protection, capturing as much as 98% of the 28.1 million CpG methylation websites within the human genome. It delivers exact single-molecule decision and allows the simultaneous detection of DNA sequence, methylation, and hydroxymethylation patterns.
“We’re excited to work intently with the Wasatch BioLabs workforce to assist facilitate a paradigm shift in methylation analysis,” mentioned Kathleen Barnes, SVP of Inhabitants Well being and Precision Drugs at ONT. “Collectively we are going to co-develop merchandise that may exchange typical applied sciences corresponding to sequencing arrays and bisulfite sequencing and reshape how methylation is included into medical analysis and diagnostics.”
ASHG 2024 Talking Occasion Announcement
From Arrays to Sequencing: Enhancing Methylation Evaluation for Biomarker Discovery and Scientific Functions
WBL will talk about this product and different key developments in a joint WBL and Oxford Nanopore CoLab session on the upcoming American Society of Human Genetics (ASHG) Annual Assembly, held November Sixth-Eighth in Denver, CO. The presentation will unveil key product particulars, together with extra sturdy particulars of MethylSeqR, a proprietary evaluation bundle designed to offer researchers with the instruments to carry out complicated analyses on sturdy native-read DNA output in minutes.
Date and time: Nov 6th at 12pm MT
Location: Colab: Theater #1
About Wasatch BioLabs
Wasatch BioLabs (WBL) is a number one R&D laboratory and next-generation sequencing service supplier devoted to advancing scientific discovery and medical epigenomics. Headquartered in Utah, WBL focuses on creating modern methylation-based applied sciences and delivering customized assays constructed for scalability, precision, and impactful outcomes. WBL’s choices empower researchers and different shoppers with unprecedented insights into the genome. With a give attention to collaboration, adaptability, and excellence, Wasatch BioLabs is a trusted accomplice for educational, biotech, and pharmaceutical industries worldwide. To be taught extra, go to www.wasatchbiolabs.com.
About Oxford Nanopore Applied sciences
Oxford Nanopore Applied sciences’ aim is to deliver the widest advantages to society via enabling the evaluation of something, by anybody, anyplace. The corporate has developed a brand new technology of nanopore-based sensing expertise for real-time, high-performance, accessible, and scalable evaluation of DNA and RNA. The expertise is utilized in greater than 125 international locations to know the biology of people and illnesses corresponding to most cancers, crops, animals, micro organism, viruses, and complete environments. Oxford Nanopore Applied sciences merchandise are meant for molecular biology purposes and aren’t meant for diagnostic functions. For extra, go to: https://nanoporetech.com/
Ahead-looking statements
This announcement incorporates sure forward-looking statements. For instance, statements relating to anticipated income progress and revenue margins are forward-looking statements. Phrases corresponding to “goal”, “plan”, “count on”, “intend”, “anticipate”, “imagine”, “estimate”, “goal”, and comparable expressions of a future or forward-looking nature also needs to be thought of forward-looking statements. Ahead-looking statements deal with our anticipated future enterprise and monetary efficiency and monetary situation, and by definition deal with issues which can be, to totally different levels, unsure. Our outcomes might be affected by macroeconomic situations, delays or challenges in manufacturing or delivering of merchandise to our prospects, suspensions of huge initiatives and/or acceleration of huge merchandise or accelerated adoption of pathogen surveillance or utilized makes use of of our merchandise. These or different uncertainties might trigger our precise future outcomes to be materially totally different than these expressed in our forward-looking statements.
For extra info, please go to:
Wasatch BioLabs: www.wasatchbiolabs.com
Oxford Nanopore Applied sciences: https://nanoporetech.com
View unique content material to obtain multimedia:https://www.prnewswire.com/news-releases/wasatch-biolabs-and-oxford-nanopore-team-up-to-accelerate-methylation-sequencing-towards-clinical-use-302294395.html
SOURCE Wasatch BioLabs
